Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

New shares issued?

masila

Aug 07, 2018 08:36AM

Re: New shares issued?

BearDownAZ

Aug 07, 2018 11:01AM

Re: New shares issued?

quest13

Aug 12, 2018 01:52PM

Re: New shares issued?

BearDownAZ

Aug 12, 2018 05:44PM

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New shares issued?

in response to

Re: New shares issued?

BearDownAZ

posted on Aug 12, 2018 08:12PM

Great answer BDAZ. That is the way I have heard it many many times. It could be sold as ZCC but most likely as ZEL or just the molecules protecting the patent for ZEN3694 packaged in a newco and then the newco sold and ZCC retaining the royalty.

tada

2 Recommendations

Re: New shares issued?

narmac

Aug 13, 2018 08:34AM

Re: New shares issued?

tada

Aug 13, 2018 08:14PM

Re: New shares issued?

narmac

Aug 14, 2018 05:27AM

Re: New shares issued?